Catalyst Wire Dossier Catalyst Wire Dossier

Alocross

· Santen SAS
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alocross, covering 2025-05-21 to 2025-05-21. Get the full timeline:

Most recent: Clinical Trial Update: 3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis [NA]

See pricing